Categories: Technology

Questor Announces the Departure of President and CEO

CALGARY, Alberta, April 20, 2026 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor” or the “Company”) (TSX-V: QST) announces the departure of President and CEO, Audrey Mascarenhas, effective today.

Audrey joined Questor in 1999 and became CEO in 2005. Under Ms. Mascarenhas’ leadership, the Company has earned a leading market position in waste gas combustion, and she leaves a legacy of strong brand recognition both domestically and on the international stage. On behalf of the employees and Board of Directors, the Company thanks Audrey for her vision, hard work, and dedication to Questor over many years, and wishes her all the best in her future endeavours.

The Board of Directors is working on a transition plan that it expects to have completed in the near term. During this transition period, Mr. Mike Lindsay will act as interim President and CEO. Ms. Mascarenhas remains a member of the Board of Directors; Paul Huizinga has assumed the role of Chair of the Board of Directors.

QUESTOR TRADES ON THE TSX VENTURE EXCHANGE UNDER THE SYMBOL ‘QST’

Aly Sumar
Chief Financial Officer
Email: investor@questortech.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

GlobeNews Wire

Recent Posts

What Separates Commercial Money Counters From Consumer Models?

MIAMI, FL, July 11, 2026 (GLOBE NEWSWIRE) -- To a first-time buyer, a consumer money…

2 hours ago

The Hidden Cost of Manual Cash Reconciliation in Cannabis Retail

MIAMI, FL, July 10, 2026 (GLOBE NEWSWIRE) -- Manual cash reconciliation is the default in…

2 hours ago

GEEKVAPE Released the 2025 Sustainability Report, Marking a Decade of Long-term Value Creation

SHENZHEN, China, July 10, 2026 (GLOBE NEWSWIRE) -- On July 1, Shenzhen Geekvape Technology Co.,…

2 hours ago

SoliVana Wellness Lab Celebrates 3 years in Redwood City as the Bay Area’s First Dedicated Nervous System Recovery Center

Founded by two former enterprise executives, SoliVana combines 16 evidence-aligned therapies across 9 private rooms…

10 hours ago

VERAXA Biotech AG Appoints Carl von Halem as InterimChief Financial Officer and Successor to Torsten Brgermeister

ZURICH, SWITZERLAND – July 10, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging…

10 hours ago

Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 10, 2026 16:05 ET  | Source: Korro Bio, Inc. CAMBRIDGE, Mass., July 10, 2026…

10 hours ago